Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

被引：55
|
作者：
Chandrasekar, PH [1 ]
Cutright, JL [1 ]
Manavathu, EK [1 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 10期
关键词：
amphotericin B; aspergillosis; guinea-pig model; micafungin; pulmonary aspergillosis; voriconazole;
D O I：
10.1111/j.1469-0691.2004.00958.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The efficacy of voriconazole in combination with amphotericin B or micafungin was studied in a transiently neutropenic guinea-pig model of invasive pulmonary aspergillosis. Guinea-pigs treated with the antifungal drugs, alone or in two-drug combinations, had an improved survival rate and reduced fungal burden in the lungs compared to untreated control animals. The efficacy of monotherapy and combination therapy was similar; activity was neither enhanced nor reduced with the two-drug combinations. Further studies of efficacy, dosing and optimal regimens for antifungal combinations are warranted.
引用
收藏
页码：925 / 928
页数：5
相关论文
共 50 条
  • [41] Cost-effectiveness of voriconazole versus amphotericin B deoxicolate for the primary treatment of invasive aspergillosis
    Aiello, EC
    Devoto, FM
    Dignani, C
    De Vedia, L
    Lorenzo, H
    VALUE IN HEALTH, 2006, 9 (03) : A155 - A155
  • [42] Cost-effectiveness of voriconazole versus liposomal amphotericin B for invasive aspergillosis infection in the UK
    Mesrobian, X
    Loftus, J
    Roberts, C
    Jansen, J
    VALUE IN HEALTH, 2005, 8 (06) : A20 - A20
  • [43] Cost-effectiveness analysis of voriconazole versus amphotericin B in the treatment of invasive aspergillosis in Spain
    Grau, S
    Mateu-de, AJ
    Soto, J
    Muñoz, M
    Salas, E
    VALUE IN HEALTH, 2003, 6 (06) : 750 - 751
  • [44] The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis
    Ibrahim, Ashraf S.
    Gebremariam, Teclegiorgis
    French, Samuel W.
    Edwards, John E., Jr.
    Spellberg, Brad
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 289 - 292
  • [45] Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis
    Clemons, KV
    Espiritu, M
    Parmar, R
    Stevens, DA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 4867 - 4875
  • [46] THE EFFECTS OF AMPHOTERICIN-B, FLUCONAZOLE AND MICONAZOLE ON NEUTROPHIL AND LYMPHOCYTE FUNCTION IN A GUINEA-PIG MODEL
    DRUMMOND, DC
    WONG, CW
    WHITMAN, LM
    MCCORMACK, JG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (02) : 375 - 384
  • [47] Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis
    Gavaldà, J
    Martín, MT
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Puigfel, Y
    Ruíz, I
    Pahissa, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 3028 - 3030
  • [48] PROPHYLACTIC INHALATION OF AMPHOTERICIN-B IN INVASIVE PULMONARY ASPERGILLOSIS - DISTRIBUTION STUDY
    BARZEN, G
    BEYER, J
    FARSHIDFAR, G
    KRAMP, W
    RICHTER, W
    FELIX, R
    NUKLEARMEDIZIN, 1993, 32 (02) : 82 - 86
  • [49] Amphotericin B nebulisation for invasive pulmonary aspergillosis prophylaxis: the conflict of ideality and reality
    Yu, Yuetian
    Zhu, Cheng
    Liu, Chunyan
    Gao, Yuan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (02) : 263 - 264
  • [50] Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis
    Xia, Di
    Sun, Wen-Kui
    Tan, Ming-Ming
    Zhang, Ming
    Ding, Yuan
    Liu, Zhi-Cheng
    Su, Xin
    Shi, Yi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 30 : 78 - 84
12345